BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 21964000)

  • 1. The significance of hurthle cells in thyroid disease.
    Cannon J
    Oncologist; 2011; 16(10):1380-7. PubMed ID: 21964000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fine-needle aspiration biopsy of Hurthle cell lesions of the thyroid gland: A cytomorphologic study of 139 cases with statistical analysis.
    Elliott DD; Pitman MB; Bloom L; Faquin WC
    Cancer; 2006 Apr; 108(2):102-9. PubMed ID: 16453320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The usefulness of 99mTc-SestaMIBI scan in the diagnostic evaluation of thyroid nodules with oncocytic cytology.
    Boi F; Lai ML; Deias C; Piga M; Serra A; Uccheddu A; Faa G; Mariotti S
    Eur J Endocrinol; 2003 Dec; 149(6):493-8. PubMed ID: 14640989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The thyroid Hürthle (oncocytic) cell and its associated pathologic conditions: a surgical pathology and cytopathology review.
    Montone KT; Baloch ZW; LiVolsi VA
    Arch Pathol Lab Med; 2008 Aug; 132(8):1241-50. PubMed ID: 18684023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fine-needle aspiration biopsy specimen with a predominance of Hürthle cells: a dilemma in the management of nodular thyroid disease.
    Alaedeen DI; Khiyami A; McHenry CR
    Surgery; 2005 Oct; 138(4):650-6; discussion 656-7. PubMed ID: 16269293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevalence and surgical outcomes of Hürthle cell lesions in FNAs of the thyroid: A multi-institutional study in 6 Asian countries.
    Agarwal S; Bychkov A; Jung CK; Hirokawa M; Lai CR; Hong S; Kwon HJ; Rangdaeng S; Liu Z; Su P; Kakudo K; Jain D
    Cancer Cytopathol; 2019 Mar; 127(3):181-191. PubMed ID: 30668897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Presence of Hürthle Cells Does Not Increase the Risk of Malignancy in Most Bethesda Categories in Thyroid Fine-Needle Aspirates.
    Ren Y; Kyriazidis N; Faquin WC; Soylu S; Kamani D; Saade R; Torchia N; Lubitz C; Davies L; Stathatos N; Stephen AE; Randolph GW
    Thyroid; 2020 Mar; 30(3):425-431. PubMed ID: 32013786
    [No Abstract]   [Full Text] [Related]  

  • 8. Hürthle cells in fine-needle aspirates of the thyroid: a review of their diagnostic criteria and significance.
    Auger M
    Cancer Cytopathol; 2014 Apr; 122(4):241-9. PubMed ID: 24436122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fine-needle aspiration cytology of thyroid nodules with Hürthle cells: cytomorphologic predictors for neoplasms, improving diagnostic accuracy and overcoming pitfalls.
    Kasper KA; Stewart J; Das K
    Acta Cytol; 2014; 58(2):145-52. PubMed ID: 24525356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hürthle cell lesions on thyroid fine needle aspiration cytology: Molecular and histologic correlation.
    Schatz-Siemers N; Brandler TC; Oweity T; Sun W; Hernandez A; Levine P
    Diagn Cytopathol; 2019 Oct; 47(10):977-985. PubMed ID: 31293091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does the fine-needle aspiration diagnosis of "Hürthle-cell neoplasm/follicular neoplasm with oncocytic features" denote increased risk of malignancy?
    Giorgadze T; Rossi ED; Fadda G; Gupta PK; Livolsi VA; Baloch Z
    Diagn Cytopathol; 2004 Nov; 31(5):307-12. PubMed ID: 15468114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotechnologist Performance for Screening Hürthle Cell Atypia in Indeterminate Thyroid Fine-Needle Aspirates.
    VandenBussche CJ; Adams C; Ali SZ; Olson MT
    Acta Cytol; 2015; 59(5):377-83. PubMed ID: 26606302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of Hürthle cells in fine needle aspiration biopsy for multinodular goitre.
    Keskek M; Ocak S; Ozalp N; Koc M; Tez M
    Endocr Regul; 2010 Apr; 44(2):65-8. PubMed ID: 20429635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignancy risk for solitary and multiple nodules in Hürthle cell-predominant thyroid fine-needle aspirations: A multi-institutional study.
    Wong KS; Jo VY; Lowe AC; Faquin WC; Renshaw AA; Shah AA; Roh MH; Stelow EB; Krane JF
    Cancer Cytopathol; 2020 Jan; 128(1):68-75. PubMed ID: 31751003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncocytic Change in Thyroid Pathology.
    Asa SL; Mete O
    Front Endocrinol (Lausanne); 2021; 12():678119. PubMed ID: 34012422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
    Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW
    Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of the Afirma Gene Expression Classifier in Hürthle Cell Thyroid Nodules Differs from Other Indeterminate Thyroid Nodules.
    Brauner E; Holmes BJ; Krane JF; Nishino M; Zurakowski D; Hennessey JV; Faquin WC; Parangi S
    Thyroid; 2015 Jul; 25(7):789-96. PubMed ID: 25962906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The key radiologic and cytomorphologic features of oncocytic and oncocytoid lesions of the salivary gland.
    Lubin D; Song S; Zafar HM; Baloch Z
    Diagn Cytopathol; 2019 Jun; 47(6):617-636. PubMed ID: 30912629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hurthle cells in fine needle aspiration cytology of the thyroid: a potential diagnostic dilemma?
    Wong YP; Md Isa N; Md Zin RR; Noor Akmal S
    Malays J Pathol; 2015 Apr; 37(1):49-52. PubMed ID: 25890614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncocytic parathyroid adenoma.
    Paul A; Villepelet A; Lefèvre M; Périé S
    Eur Ann Otorhinolaryngol Head Neck Dis; 2015 Nov; 132(5):301-3. PubMed ID: 26364541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.